capecitabine has been researched along with Hepatitis D in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandi, G; Brocchi, S; De Lorenzo, S; Di Federico, A; Frega, G; Golfieri, R; Morelli, MC; Palloni, A; Rizzo, A; Vasuri, F | 1 |
1 other study(ies) available for capecitabine and Hepatitis D
| Article | Year |
|---|---|
The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
Topics: Administration, Metronomic; Adult; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis D; Humans; Liver Neoplasms; Male; Patient Acuity | 2022 |